đźšš Free Worldwide Shipping on All Orders!Shop Now
\n

Disclaimer: This test information is provided for general awareness and does not replace professional medical advice. Test reports must be interpreted by a qualified healthcare professional. Read our disclaimer policy.

\n

Image generated using Google Gemini and Shopify Magic.

\n","image":["/images/healthcarentsickcarestore.shop/images/product/ca-19-9-test-1.avif"],"sku":"ca-19-9-test","brand":{"@type":"Brand","name":"healthcare nt sickcare"},"offers":{"@type":"AggregateOffer","lowPrice":849,"highPrice":849,"priceCurrency":"USD","availability":"https://schema.org/InStock","url":"https://healthcarentsickcarestore.shop/products/ca-19-9-test","offerCount":1}}
HomeStore

CA-19-9 Test

Product image 1

CA-19-9 Test

About the CA-19-9 Test

Direct answer: The CA-19-9 test is a blood test used to monitor pancreatic and digestive tract cancers by measuring a tumour marker protein.

The CA-19-9 Test measures cancer antigen-19-9 (CA-19-9). Definition: CA-19-9 is a tumour marker — a protein released into the bloodstream by certain pancreatic and gastrointestinal cancer cells. A tumour marker is a measurable blood substance that helps track cancer activity and treatment response.

This test is commonly advised for monitoring pancreatic cancer, biliary tract cancer, or follow-up after treatment. Definition: Cancer follow-up testing refers to periodic blood monitoring used to detect recurrence after therapy. At healthcare nt sickcare, the CA-19-9 test is available with a Home Collection Facility across Pune and a Direct Walk-in Facility, supporting timely tumour marker monitoring in Maharashtra.

Sample & Method

A blood sample is collected through venepuncture (blood drawn from a vein) and analysed using validated immunoassay laboratory techniques to measure CA-19-9 concentration.

Related Resources

Read diagnostic education in our health articles. Check preparation guidance in our test preparation guides. Compare preventive screening options on our health checkup comparison page. Explore diagnostic facilities on our services.

Frequently Asked Questions

The CA-19-9 Test is recommended for monitoring pancreatic or biliary tract cancers and for follow-up after cancer treatment.
Clinicians use this test to track tumour marker changes, helping assess treatment response or detect possible cancer recurrence.
No fasting is required for the CA-19-9 Test unless additional blood tests booked together need preparation.
Persistent abdominal pain, unexplained weight loss, jaundice, or pancreatic disease follow-up may prompt CA-19-9 testing.

Disclaimer: This test information is provided for general awareness and does not replace professional medical advice. Test reports must be interpreted by a qualified healthcare professional. Read our disclaimer policy.

Image generated using Google Gemini and Shopify Magic.

$849.00
CA-19-9 Test—
$849.00

Product Information

Shipping & Returns

Description

About the CA-19-9 Test

Direct answer: The CA-19-9 test is a blood test used to monitor pancreatic and digestive tract cancers by measuring a tumour marker protein.

The CA-19-9 Test measures cancer antigen-19-9 (CA-19-9). Definition: CA-19-9 is a tumour marker — a protein released into the bloodstream by certain pancreatic and gastrointestinal cancer cells. A tumour marker is a measurable blood substance that helps track cancer activity and treatment response.

This test is commonly advised for monitoring pancreatic cancer, biliary tract cancer, or follow-up after treatment. Definition: Cancer follow-up testing refers to periodic blood monitoring used to detect recurrence after therapy. At healthcare nt sickcare, the CA-19-9 test is available with a Home Collection Facility across Pune and a Direct Walk-in Facility, supporting timely tumour marker monitoring in Maharashtra.

Sample & Method

A blood sample is collected through venepuncture (blood drawn from a vein) and analysed using validated immunoassay laboratory techniques to measure CA-19-9 concentration.

Related Resources

Read diagnostic education in our health articles. Check preparation guidance in our test preparation guides. Compare preventive screening options on our health checkup comparison page. Explore diagnostic facilities on our services.

Frequently Asked Questions

The CA-19-9 Test is recommended for monitoring pancreatic or biliary tract cancers and for follow-up after cancer treatment.
Clinicians use this test to track tumour marker changes, helping assess treatment response or detect possible cancer recurrence.
No fasting is required for the CA-19-9 Test unless additional blood tests booked together need preparation.
Persistent abdominal pain, unexplained weight loss, jaundice, or pancreatic disease follow-up may prompt CA-19-9 testing.

Disclaimer: This test information is provided for general awareness and does not replace professional medical advice. Test reports must be interpreted by a qualified healthcare professional. Read our disclaimer policy.

Image generated using Google Gemini and Shopify Magic.